我武生物 (300357)

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

ASZ

Tags

Specialized-Sophisticated-Distinctive-Innovative EnterprisesArtificial Intelligence (AI)Innovative DrugsPharmaceutical ManufacturingSocial Security Fund Heavy PositionsHigh-Performing StocksMargin Trading and Securities LendingChiNext 200 IndexChiNext 300 IndexChiNext Blue ChipChiNext Healthcare

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 52358.40
  • Circulating A-Shares(W): 48406.42
  • Earnings Per Share(RMB): 0.6587
  • Net Assets Per Share(RMB): 5.0340
  • Operating Revenue(W RMB): 85336.04
  • Total Profit(W RMB): 39427.84
  • Net Profit Attributable to Parent(W RMB): 34486.65
  • Net Profit Growth Rate(%): 26.67
  • Weighted Return on Equity(%): 13.8000
  • Operating Cash Flow Per Share(RMB): 0.5480
  • Undistributed Profit Per Share(RMB): 3.2721
  • Capital Reserve Per Share(RMB): 0.2448

2. Main Business

The main business covers:

  • Research, production and sales of diagnostic and therapeutic products for allergic diseases

3. Company Basic Information

  • Company Name: Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
  • Listing Date: 2014-01-21
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 636 Zhiyuan North Road, Wukang Town, Deqing County, Huzhou City, Zhejiang Province
  • Website: www.wolwobiotech.com
  • Company Profile: The issuer's predecessor was Zhejiang Wolwo Biotechnology Co., Ltd., established on September 19, 2002. The issuer was established as a joint stock company through the overall change of Wolwo Co., Ltd., which contributed its audited net assets of RMB 90,380,637.31 as of December 31, 2010 as capital contribution, converted into shares at a ratio of 1:0.9958, totaling RMB 90,000,000. On February 18, 2011, the issuer obtained the "Business License" (Registration No.: 330500400002475) issued by the Huzhou Administration for Industry and Commerce of Zhejiang Province, with a registered capital of RMB 90 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhejiang Wolwo Management Consulting Co., Ltd. General Legal Person 20345.41 42.03
2 National Social Security Fund 112 Portfolio Social Security Fund 2608.11 5.39
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 556.20 1.15
4 Harvest Mutual Selection Equity Securities Investment Fund Class A Fund 471.18 0.97
5 Penghua Pharmaceutical Technology Equity Securities Investment Fund Class A Fund 429.86 0.89
6 China Merchants Guozheng Bio-medicine Index Securities Investment Fund (LOF) Class A Fund 390.68 0.81
7 Dacheng ChiNext Two-Year Regular Open Hybrid Securities Investment Fund Class A Fund 211.48 0.44
8 Penghua Medical Care Equity Securities Investment Fund Fund 80.84 0.17
9 Penghua Pension Industry Equity Securities Investment Fund Fund 73.47 0.15
10 Dacheng Quality Medical Equity Securities Investment Fund Class A Fund 58.62 0.12

5. Concept Sectors

  • Artificial Intelligence
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Heavy Holdings by Social Security Fund
  • Specialized, Refined, Special and New Enterprises
  • ChiNext 300
  • ChiNext Blue Chips
  • ChiNext Growth
  • ChiNext Quality
  • ChiNext Pharmaceuticals
  • ChiNext 200

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information